                </a></li></ul></div><p><strong>Figure 2.  <span>Sequence comparison between SENP8 and its homologs in human pathogenic bacteria.</span></strong></p><a id="article1.body1.sec2.fig2.caption1.p1" name="article1.body1.sec2.fig2.caption1.p1"></a><p>Multiple sequence alignment of the catalytic core region of human SENP8 (NCBI protein sequence identifier GI: 33942066, shown are residues 100–165) with the homologs in <em>C. trachomatis</em> (CT868, GI: 76789615, residues 199–284) <a href="#pone.0000381-Misaghi1">[23]</a>, <em>E. coli</em> (elaD, GI: 15832411, residues 228–319), <em>L. pneumophila</em> (GI: 52843101, residues 189–265), and <em>S. typhi</em> (sseL, GI: 29141091, residues 197–264) <a href="#pone.0000381-Rytkonen1">[42]</a>. The arrows indicate active-site histidine, aspartate (or asparagine), the catalytic cysteine, and the oxyanion-stabilizing group. Predicted secondary structures are shown at the bottom and have been confirmed with the solved structure of SENP8 <a href="#pone.0000381-Shen1">[27]</a>.</p>
<span>THISISTHEEND
